Bristol Myers Squibb
Generated by Meeveem AI
"Discovery, development, manufacturing and supply of medicines for serious diseases"
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company headquartered in Princeton, NJ, USA. It discovers, develops and delivers medicines for serious diseases, including cancer, blood disorders, immune conditions and cardiovascular disease. Its research platforms include cell therapies, protein degraders, biologics and radiopharmaceutical treatments.
The business traces its history to 1887 and took its present name following a merger in 1989. It reported approximately 32,500 employees across 43 countries at the end of 2025. Its UK workforce numbers more than 800 people, with work spanning medicine development, clinical studies, medicines access and business services.
How UK teams are organised
The UK business combines site-based work with geographically aligned medical, clinical operations and commercial teams. Medical affairs, pharmacovigilance and regulatory colleagues work alongside clinical operations, commercial and business support teams.
Learning and progression
Employees have access to online learning resources and career development tools. BMS describes coaching, mentoring and stretch assignments, which may include rotations, moves between business functions or project work. Its tuition reimbursement policy supports further education aligned with an employee’s goals and the company’s mission.
32500
Team Members
1887
Founded
Pharma
Sector
Hybrid
Work Environment